GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk - Medical News Today
Scientists have found that GLP-1 medications, such as Ozempic, and Wegovy, is linked to a decrease in the overall risk of developing obesity-related cancers, especially with colorectal, pancreatic, and endometrial cancers.